Lawrence Steinman Bio Atla, Inc. (BCAB) insider trading activity

Lawrence Steinman is of BioAtla, Inc.. Currently has a direct ownership of 54,959 shares of BCAB, which is worth approximately $91,231. The most recent transaction as insider was on Jun 13, 2024, when has been sold 16,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 55K

0% 3M change

197.74% 12M change

Total Value Held $91,231

LAWRENCE STEINMAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 13 2024	BUY Grant, award, or other acquisition	-	16,500 Added 23.09%	54,959 Common Stock
Dec 19 2023	BUY Open market or private purchase	$41,000 $2.05 p/Share	20,000 Added 34.21%	38,459 Common Stock
Nov 02 2021	SELL Open market or private sale	$13,500 $30.0 p/Share	450 Reduced 2.38%	18,459 Common Stock
Sep 15 2021	SELL Open market or private sale	$16,569 $36.82 p/Share	450 Reduced 2.32%	18,909 Common Stock
Aug 16 2021	SELL Open market or private sale	$18,270 $40.6 p/Share	450 Reduced 2.27%	19,359 Common Stock
Jul 15 2021	SELL Open market or private sale	$17,231 $38.29 p/Share	450 Reduced 2.22%	19,809 Common Stock
Jun 14 2021	BUY Other acquisition or disposition	-	5,388 Added 21.01%	20,259 Common Stock

Also insider at

ATNF

180 Life Sciences Corp. Healthcare

Director

KTTA

Pasithea Therapeutics Corp. Healthcare

Director